Effect of ozanimod on circulating leukocyte subtypes in patients with relapsing multiple sclerosis and comparison with healthy volunteers

被引：0
|
作者：
Harris, S. [1 ]
Maddux, R. [1 ]
Hoffmueller, U. [2 ]
Raschke, E. [2 ]
机构：
[1] Bristol Myers Squibb, Princeton, NJ USA
[2] Precis Med GmbH, Berlin, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P659
引用
收藏
页码：567 / 567
页数：1
相关论文
共 50 条
  • [1] Effect Of Ozanimod On Circulating Leukocyte Subtypes In Patients With Relapsing Multiple Sclerosis: Results From A Phase 1 Study
    Harris, S.
    Tran, J. Q.
    Southworth, H.
    Spencer, C. M.
    Cree, B. A.
    Zamvil, S. S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 60 - 60
  • [2] Effect of ozanimod on proportions of leukocyte subsets in patients with relapsing multiple sclerosis
    Harris, S.
    Tran, J.
    Southworth, H.
    Spencer, C.
    Cree, B.
    Zamvil, S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 277 - 277
  • [3] Effect of ozanimod on circulating leukocyte subtypes: data from a randomised, open-label, phase 1 study in patients with relapsing multiple sclerosis
    Harris, S.
    Tran, J. Q.
    Cree, B. A. C.
    Southworth, H.
    Spencer, C. M.
    Zamvil, S. S.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 526 - 527
  • [4] Ozanimod for the treatment of relapsing remitting multiple sclerosis
    Rasche, Ludwig
    Paul, Friedemann
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (18) : 2073 - 2086
  • [5] Ozanimod: A Review in Relapsing Forms of Multiple Sclerosis
    Nie, Tina
    Syed, Yahiya Y.
    CNS DRUGS, 2024, 38 (11) : 931 - 941
  • [6] Ozanimod for the treatment of relapsing forms of multiple sclerosis
    Kuczynski, Andrea M.
    Oh, Jiwon
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2021, 11 (03) : 207 - 220
  • [7] Effect of the sphingosine-1-phosphate receptor modulator ozanimod on leukocyte subtypes in relapsing MS
    Harris, Sarah
    Tran, Jonathan Q.
    Southworth, Harry
    Spencer, Collin M.
    Cree, Bruce A. C.
    Zamvil, Scott S.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (05):
  • [8] Extended Serologic Responses to SARS-CoV-2 Vaccination in Healthy Volunteers and DAYBREAK Participants With Relapsing Multiple Sclerosis Receiving Ozanimod
    Cree, Bruce
    Maddux, Rachel
    Bar-Or, Amit
    Hartung, Hans-Peter
    Kaur, Amandeep
    Li, Yicong
    Fu, Kai
    Hu, Yanhua
    Sheffield, James
    Silva, Diego
    Harris, Sarah
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1074 - 1074
  • [9] Safety of the Concurrent Administration of Serotonergic Antidepressants and Ozanimod in Patients With Relapsing Multiple Sclerosis
    Naismith, R. T.
    Cohen, J. A.
    Bar-Or, A.
    Comi, G.
    Selmaj, K. W.
    Hartung, H.
    Sheffield, J. K.
    Krakovich, A.
    Cheng, C.
    Reardon, J.
    Riolo, J. V.
    Silva, D.
    Cree, B. A.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 98 - 99
  • [10] Impact of ozanimod on absolute lymphocyte count and recovery in patients with relapsing multiple sclerosis
    Selmaj, K. W.
    Cree, B. A. C.
    Cohen, J. A.
    Hartung, H. -P.
    Sheffield, J. K.
    Harris, S.
    Cheng, C. -Y.
    Riolo, J. V.
    Bar-Or, A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 854 - 854
12345